Published on : Sep 06, 2016
ALBANY, New York, September 06, 2016: Market Research Hub has added a new report to their repository titled “American Bio Medica Corporation (ABMC) - Product Pipeline Analysis, 2016 Update.” The report is a detailed analysis of the growth trajectory and future growth prospects of the American Bio Medica Corporation (ABMC) pipeline products. The study is a significant source of statistics and data related to the company and market intelligence information on the portfolio of the company regarding its pipeline products. The study also provides essential information about the major products and brands of the company.
The report provides in-depth analysis of the business, strategies, key services and products, main competitors, recent developments, and subsidiaries. The study also articulates the various pipeline products that are still in the development process for American Bio Medica Corporation. Furthermore, the report presents a detailed description of the manufacturing process of pipeline products, applications, ongoing clinical trials, technical specifications, functions, and projected launch date of the pipeline products.
American Bio Medica Corporation (ABMC) is a company that operates in the biotechnology sector. It is engaged in the development, manufacturing, and marketing of immunoassay test kits. Rapid TOX, Rapid One, Rapid Drug Screen, and OralStat among others are some of the key products of American Bio Medica Corporation. As a part of its value added services, it provides contract manufacturing services for bulk test strips. American Bio Medica Corporation serves several sectors such as education, government, and drug and rehabilitation among others.
American Bio Medica Corporation operates in the immunoassay test kits market, which is likely to be driven by factors such as the mounting cases of infectious and chronic diseases, growing pharmaceuticals and biotechnology industries, cost-effectiveness and sensitivity offered by immunoassay test kits, high use of immunoassay test kits in oncology, rise in geriatric population across the world, and technological advancements. However, the progress of the American Bio Medica Corporation is likely to be restrained by the high excise duty implemented by the U.S. government. Furthermore, as the detection limit of immunoassay test kits is comparatively low, their adoption is likely to be inhibited in the coming years.
Click here to get more info with TOC in a PDF Format: http://www.marketresearchhub.com/enquiry.php?type=S&repid=772245
American Bio Medica Corporation (ABMC) is also expected to face challenges from the other stringent regulatory procedures the U.S. government and the pressure of pricing arising from competitors such as Abbott Laboratories, Ortho Clinical Diagnostics, and Bechman Coulter. In spite of the restraining factors prevailing in the market, American Bio Medica Corporation can gain advantage from the ongoing research activities being undertaken to automate laboratories and point-of-care testing.
The report also has a comprehensive set of tables and figures to provide insight into the development, type, status, and specification of various pipeline products of the American Bio Medica Corporation (ABMC).
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : email@example.com